Patents by Inventor Waldemare Priebe

Waldemare Priebe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer treatment including glycolytic inhibitors
    Patent number: 7338940
    Abstract: Glycolytic inhibitors are useful in the treatment of solid tumors by attacking anaerobic cells at the center on the tumor. 2-deoxyglucose, oxamate and various analogs thereof are identified as having a natural selective toxicity toward anaerobic cells, and will significantly increase the efficacy of standard cancer chemotherapeutic and radiation regiments as well as new protocols emerging with anti-angiogenic agents.
    Type: Grant
    Filed: September 16, 2005
    Date of Patent: March 4, 2008
    Inventors: Theodore J. Lampidis, Waldemare Priebe
  • Cancer treatment including glycolytic inhibitors
    Publication number: 20060025351
    Abstract: Glycolytic inhibitors are useful in the treatment of solid tumors by attacking anaerobic cells at the center on the tumor. 2-deoxyglucose, oxamate and various analogs thereof are identified as having a natural selective toxicity toward anaerobic cells, and will significantly increase the efficacy of standard cancer chemotherapeutic and radiation regiments as well as new protocols emerging with anti-angiogenic agents.
    Type: Application
    Filed: September 16, 2005
    Publication date: February 2, 2006
    Inventors: Theodore Lampidis, Waldemare Priebe
  • Cancer treatment including glycolytic inhibitors
    Publication number: 20050043250
    Abstract: Glycolytic inhibitors are useful in the treatment of solid tumors by attacking anaerobic cells at the center on the tumor. 2-deoxyglucose, oxamate and various analogs thereof are identified as having a natural selective toxicity toward anaerobic cells, and will significantly increase the efficacy of standard cancer chemotherapeutic and radiation regiments as well as new protocols emerging with anti-angiogenic agents.
    Type: Application
    Filed: September 29, 2004
    Publication date: February 24, 2005
    Inventors: Theodore Lampidis, Waldemare Priebe
  • Cancer chemotherapy with 2-deoxy-D-glucose
    Patent number: 6670330
    Abstract: A class of glycolytic inhibitors is useful in the treatment of solid tumors by attacking anaerobic cells at the center on the tumor. 2-deoxyglucose, oxamate and various analogs thereof are identified as having a natural selective toxicity toward anaerobic cells, and will significantly increase the efficacy of standard cancer chemotherapeutic and radiation regiments as well as new protocols emerging with anti-angiogenic agents.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: December 30, 2003
    Inventors: Theodore J. Lampidis, Waldemare Priebe
  • Cancer treatment including glycolytic inhibitors
    Publication number: 20030181393
    Abstract: Glycolytic inhibitors are useful in the treatment of solid tumors by attacking anaerobic cells at the center on the tumor. 2-deoxyglucose, oxamate and various analogs thereof are identified as having a natural selective toxicity toward anaerobic cells, and will significantly increase the efficacy of standard cancer chemotherapeutic and radiation regiments as well as new protocols emerging with anti-angiogenic agents.
    Type: Application
    Filed: March 28, 2003
    Publication date: September 25, 2003
    Inventors: Theodore J. Lampidis, Waldemare Priebe